N/A
Completed N=1,001
PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure
Heart Failure, Congestive
Source: ClinicalTrials.gov NCT00279955 ↗
Enrolled (actual)
1,001
Serious AEs
29.7%
Results posted
Dec 2011
Primary outcomePrimary: Occurrence of Heart Failure (HF) Related Adverse Event (AE) — 29; 50 participants — p=0.0119
Summary
The purpose of this study is to determine the value of diagnostic data obtained from Medtronic implantable cardioverter defibrillators (ICDs) with cardiac resynchronization therapy (CRT) to evaluate cardiovascular and heart failure related adverse events and health care utilization.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Occurrence of Heart Failure (HF) Related Adverse Event (AE) |
29; 50 | 0.0119 sig |
| SECONDARY Occurrence of Heart Failure (HF) Related Healthcare Utilization (HU) |
22; 35 | 0.0185 sig |
| SECONDARY Occurrence of Heart Failure (HF) Related Pulmonary Congestion Event (PCE) |
17; 28 | 0.0578 |
Eligibility Criteria
Inclusion Criteria
- Patients who meet the ICD indications
- Patients with Class III or IV heart failure.
- Patients receiving or who received a Medtronic CRT ICD within the previous 3 months.
- Patient must sign and date informed consent, and be 18 years of age or greater.
- Patient must be available for follow up visits, and be willing and able to comply with study protocol.
Exclusion Criteria
- Patient with acute myocardial infarction (MI), coronary artery bypass graft surgery (CABG) or percutaneous coronary angioplasty (PTCA)/stent within the last month.
- Patient with a mechanical right heart valve.
- Patient with chronic (permanent) atrial arrhythmias.
- Patient with life expectancy of less than 12 months.
- Patient with status post heart transplant
- Patient undergoing kidney dialysis
- Patients enrolled in a concurrent study that may confound the results of the study.
Data sourced from ClinicalTrials.gov (NCT00279955). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.